International Society on Thrombosis and Haemostasis

Welcome to the ISTH The Pulse podcast, where we pull back the curtain on the latest in the field of thrombosis and hemostasis.

Hosted by Dr. Julia Sandrin-Gower, join us for in-depth conversations with some of the world's top experts, from updates on cutting-edge research and science to unique stories from members of our global community.

Hello, everyone, and welcome back to the ISTH Pulse podcast.

Today, we're going to be exploring what can happen when patients aren't just participants in research, but rather they're partners in shaping it.

Our guests today, Dr. Sudeep Sivakumar and Carol West, are both joining us from Canada, and we'll be discussing how bringing lived experience from patients into the clinical trial design can influence the questions that we ask, the priorities that we consider, and ultimately the care that we provide.

Welcome both to the podcast.

Thank you so much, and, uh, really thanks to the ISTH and yourself, Julia, for the opportunity.

And echo Sudeep's comments.

Welcome to the ISTH The Pulse podcast, where we pull back the curtain on the latest in the field of thrombosis and hemostasis, hosted by Dr. Geoffrey Barnes.

Join us for in-depth conversations with some of the world's top experts, from updates on cutting-edge research and science, to unique stories from members of our global community.

Welcome back to the ISTH Pulse podcast.

As you probably know, World Thrombosis Day is coming up on October 13th.

And this year, the campaign is putting a special focus on women's health and blood clots.

Jim, thanks for highlighting the Women's Health Hub.

We're certainly going to put a link to that in the show notes for this podcast episode.

But you also highlighted another product that ISTH has been focused on, which is the Lancet Hematology Commission on Global Female Health.

Hi, everyone, and welcome back to the ISTH Pulse podcast.

I'm your host, Dr. Geoffrey Barnes, and today we're bringing you the podcast in a special format.

Just for this week, we're dropping a three-episode miniseries focused on antithrombotic strategies.

So, uh, you know, I think the efficacy is excellent.

The safety, very good as well.

So the primary safety outcome, which was ISTH major hemorrhage, was not increased, and we saw similar rates of the secondary outcomes.

Importantly, similar rates of intracranial hemorrhage and similar rates of intracerebral hemorrhage with asundexian compared to placebo.

The other thing that patients told us was very important to them was minor bleeding.

Thank you for listening to the ISTH Pulse Podcast.

Learn more about today's episode at www.isth.org and make sure to hit the follow button for the Pulse Podcast so you'll be notified each time a new episode drops.

Welcome to the ISTH The Pulse podcast, where we pull back the curtain on the latest in the field of thrombosis and hemostasis.

Hosted by Dr. Julia Sandrin-Gower, join us for in-depth conversations with some of the world's top experts, from updates on cutting-edge research and science to unique stories from members of our global community.

Hello and welcome to the ISTH Falls podcast, where we explore the latest advances in thrombosis and hemostasis.

Today, we're really excited to collaborate on a special episode with our partners at Vascular Network to discuss a frequently requested topic amongst patients and healthcare professionals alike.

and that is GLP-1 receptor agonists, or simply called GLP-1s.

Thank you for having us.

And thank you for listening.

We'll see you next time on the ISTH Pulse Podcast.

Welcome to the ISTH The Pulse podcast, where we pull back the curtain on the latest in the field of thrombosis and hemostasis.

Hosted by Dr. Julia Sandrin-Gower, join us for in-depth conversations with some of the world's top experts, from updates on cutting-edge research and science to unique stories from members of our global community.

Hello and welcome to the ISTH Falls podcast, where we explore the latest advances in thrombosis and hemostasis.

Today, we're really excited to collaborate on a special episode with our partners at Vascular Network to discuss a frequently requested topic amongst patients and healthcare professionals alike.

and that is GLP-1 receptor agonists, or simply called GLP-1s.

Thank you for having us.

And thank you for listening.

We'll see you next time on the ISTH Pulse Podcast.